Literature DB >> 19879975

Genetic diversity and molecular evolution of human and non-human primate Gammaherpesvirinae.

Vincent Lacoste1, Anne Lavergne, Benoît de Thoisy, Jean-François Pouliquen, Antoine Gessain.   

Abstract

The Gammaherpesvirinae sub-family is divided into two genera: Lymphocryptovirus and Rhadinovirus. Until the middle of the 1990s, the Rhadinovirus genus was only represented by Herpesvirus saimiri and Herpesvirus ateles, which infect New World monkey species. Until the year 2000, Epstein-Barr virus (EBV), the human prototype of the Lymphocryptovirus, and simian homologues had only been detected in humans and Old World non-human primates. It was thought, therefore, that the separation of the continents had resulted in drastic changes in Gammaherpesvirinae evolution. The discovery of Kaposi's sarcoma-associated herpesvirus in humans, belonging to the Rhadinovirus, followed by the identification of CalHV3 (Callitrichine herpesvirus 3), a lymphocryptovirus of the marmoset, challenged this paradigm. The description of numerous viruses belonging to this sub-family from various Old and New World primate species enabled a cospeciation hypothesis for these viruses and their hosts to be developed. This review focuses on the current knowledge of primate Gammaherpesvirinae genetic diversity and molecular evolution. We discuss the various theories based on current genetic data regarding evolutionary relationships between lymphocryptoviruses of Old World primates, the use of these data as a tool to study evolutionary relationships between New World monkey species, and the possible existence of a ninth human herpesvirus belonging to the Rhadinovirus genus. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19879975     DOI: 10.1016/j.meegid.2009.10.009

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  9 in total

1.  EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA.

Authors:  Nara Lee; Walter N Moss; Therese A Yario; Joan A Steitz
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

Review 2.  Microbiome and malignancy.

Authors:  Claudia S Plottel; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

Review 3.  Endemic Viruses of Squirrel Monkeys (Saimiri spp.).

Authors:  Donna L Rogers; Gloria B McClure; Julio C Ruiz; Christian R Abee; John A Vanchiere
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

4.  African great apes are naturally infected with roseoloviruses closely related to human herpesvirus 7.

Authors:  Anne Lavergne; Damien Donato; Antoine Gessain; Henk Niphuis; Eric Nerrienet; Ernst J Verschoor; Vincent Lacoste
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

5.  Noncoding RNA-guided recruitment of transcription factors: A prevalent but undocumented mechanism?

Authors:  Nara Lee; Joan A Steitz
Journal:  Bioessays       Date:  2015-07-22       Impact factor: 4.345

Review 6.  KSHV targeted therapy: an update on inhibitors of viral lytic replication.

Authors:  Natacha Coen; Sophie Duraffour; Robert Snoeck; Graciela Andrei
Journal:  Viruses       Date:  2014-11-24       Impact factor: 5.048

Review 7.  Insights on the cGAS-STING Signaling Pathway During Herpesvirus Infections.

Authors:  Lishuang Deng; Zhiwen Xu; Fengqin Li; Jun Zhao; Zhijie Jian; Huidan Deng; Siyuan Lai; Xiangang Sun; Yi Geng; Ling Zhu
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

8.  CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity, and KIR expression.

Authors:  Alexander T H Cocker; Fuguo Liu; Zakia Djaoud; Lisbeth A Guethlein; Peter Parham
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

9.  Induction of encephalitis in rhesus monkeys infused with lymphocryptovirus-infected B-cells presenting MOG(34-56) peptide.

Authors:  Krista G Haanstra; Jacqueline A M Wubben; Margreet Jonker; Bert A 't Hart
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.